New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
07:48 EDTPKI, A, DHRPerkinElmer, Agilent unit seen as potential Danaher targets, Bloomberg says
With Danaher (DHR) having recently lost out to private equity firms on buyout targets it was seeking, analysts at Janney Montgomery Scott speculated that the conglomerate could set its sights on targets such as PerkinElmer (PKI), Agilent's (A) life sciences unit, or an international target like Oxford Instruments of the U.K., said Bloomberg's "Real M&A" column. Citigroup analysts suggest Danaher could also consider a breakup instead of an acquisition, the report noted. Reference Link
News For DHR;A;PKI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 22, 2015
10:03 EDTDHROn the Fly: Analyst Initiation Summary
Subscribe for More Information
January 21, 2015
16:13 EDTDHRDanaher initiated with a Buy at UBS
Target $100.
January 13, 2015
12:08 EDTDHRDanaher repeats FY15 adjusted EPS view $4.35-$4.45
Subscribe for More Information
January 12, 2015
10:00 EDTDHROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:10 EDTADako, Cell Signaling Technology announce partnership
Dako, an Agilent Technologies company, and Cell Signaling Technology, or CST, a worldwide provider of antibodies, announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products. The financial details of the agreement were not disclosed.
09:04 EDTAAgilent's Dako unit, Cell Signaling Technology announce strategic partnership
Dako, an Agilent Technologies company and a worldwide provider of cancer diagnostics, and Cell Signaling Technology announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products. The financial details of the agreement were not disclosed.
08:06 EDTDHRDanaher downgraded at Morgan Stanley
As previously reported, Morgan Stanley downgraded Danaher to Equal Weight from Equal Weight. The firm views risk/reward more balanced and notes incremental earnings headwinds in Europe. Price target is $88.
06:44 EDTDHRDanaher downgraded to Equal Weight from Overweight at Morgan Stanley
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use